A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.
Maraninchi D, Vey N, Viens P, Stoppa AM, Archimbaud E, Attal M, Baume D, Bouabdallah R, Demeoq F, Fleury J, Michallet M, Olive D, Reiffers J, Sainty D, Tabilio A, Tiberghien P, Brandely M, Hercend T, Blaise D.
Maraninchi D, et al. Among authors: tabilio a.
Leuk Lymphoma. 1998 Oct;31(3-4):343-9. doi: 10.3109/10428199809059227.
Leuk Lymphoma. 1998.
PMID: 9869198
Clinical Trial.